Quest Diagnostics 2003 Annual Report Download - page 47

Download and view the complete annual report

Please find page 47 of the 2003 Quest Diagnostics annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 109

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109

10.1 Form of 6
3
⁄
4
% Senior Notes due 2006, including the form of guarantee endorsed thereon (filed as
an Exhibit to the Company’s current report on Form 8-K (Date of Report: June 27, 2001) and
incorporated herein by reference)
10.2 Form of 7
1
⁄
2
% Senior Notes due 2011, including the form of guarantee endorsed thereon (filed as
an Exhibit to the Company’s current report on Form 8-K (Date of Report: June 27, 2001) and
incorporated herein by reference)
10.3 Form of 1.75% Contingent Convertible Debentures due 2021, including the form of guarantee
endorsed thereon (filed as an Exhibit to the Company’s current report on Form 8-K (Date of
Report: November 26, 2001) and incorporated herein by reference)
10.4 Indenture dated as of June 27, 2001, among the Company, the Subsidiary Guarantors, and the
Trustee (filed as an Exhibit to the Company’s current report on Form 8-K (Date of Report:
June 27, 2001) and incorporated herein by reference)
10.5 First Supplemental Indenture, dated as of June 27, 2001, among the Company, the Subsidiary
Guarantors, and the Trustee to the Indenture referred to in Exhibit 10.4 (filed as an Exhibit to
the Company’s current report on Form 8-K (Date of Report: June 27, 2001) and incorporated
herein by reference)
10.6 Second Supplemental Indenture, dated as of November 26, 2001, among the Company, the
Subsidiary Guarantors, and the Trustee to the Indenture referred to in Exhibit 10.4 (filed as an
Exhibit to the Company’s current report on Form 8-K (Date of Report: November 26, 2001) and
incorporated herein by reference)
10.7 Third Supplemental Indenture, dated as of April 4, 2002, among Quest Diagnostics, the
Additional Subsidiary Guarantors, and the Trustee to the Indenture referred to in Exhibit 10.4
(filed as an Exhibit to the Company’s current report on Form 8-K (Date of Report: April 1,
2002) and incorporated herein by reference)
10.8 Fourth Supplemental Indenture dated as of March 19, 2003, among Unilab Corporation (f/k/a
Quest Diagnostics Newco Incorporated), Quest Diagnostics Incorporated, The Bank Of New York,
and the Subsidiary Guarantors (filed as an Exhibit to the Company’s quarterly report on
Form 10-Q for the quarter ended March 31, 2003 and incorporated herein by reference)
10.9 Credit Agreement, dated as of June 27, 2001, among the Company, the Subsidiary Guarantors
and the Banks (filed as an Exhibit to the Company’s current report on Form 8-K (Date of
Report: June 27, 2001) and incorporated herein by reference)
10.10 Second Amended and Restated Credit and Security Agreement dated as of September 30, 2003
among Quest Diagnostics Receivables Inc., as Borrower, Quest Diagnostics Incorporated, as
Servicer, each of the lenders party thereto and Wachovia Bank, National Association, as
Administrative Agent (filed as an Exhibit to the Company’s quarterly report on Form 10-Q for
the quarter ended September 30, 2003 and incorporated herein by reference)
10.11 Amended and Restated Receivables Sale Agreement dated as of September 30, 2003 among
Quest Diagnostics Incorporated and each of its direct or indirect wholly owned subsidiaries who
is or hereafter becomes a seller hereunder, as the Sellers, and Quest Diagnostics Receivables Inc.,
as the Buyer (filed as an Exhibit to the Company’s quarterly report on Form 10-Q for the quarter
ended September 30, 2003 and incorporated herein by reference)
10.12 Term Loan Credit Agreement dated as of June 21, 2002 among Quest Diagnostics Incorporated,
certain subsidiary guarantors of the Company, the lenders party thereto, and Bank of America,
N.A., as Administrative Agent (filed as an Exhibit to the Company’s Registration Statement on
Form S-4 (No. 333-88330) and incorporated herein by reference)
10.13 First Amendment to Credit Agreement dated as of September 20, 2002 among Quest Diagnostics
Incorporated, certain subsidiary guarantors of the Company, the lenders party thereto, and Bank
of America, N.A., as Administrative Agent (filed as an Exhibit to the Company’s quarterly report
on Form 10-Q for the quarter ended September 30, 2002 and incorporated herein by reference)
10.14 Second Amendment to Credit Agreement dated as of December 19, 2002 among Quest
Diagnostics Incorporated, certain subsidiary guarantors of the Company, the lenders party thereto,
and Bank of America, N.A., as Administrative Agent (filed as an Exhibit to post effective
Amendment No. 1 to the Company’s Registration Statement on Form S-4 (No. 333-88330) and
incorporated herein by reference)
30